Search

everythinglearnresearchcommunity

for

Search:↓

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Endothelin-1 helps amelanotic melanocytes stick and move better on certain proteins.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

Fibroblast and endothelial cell interactions are crucial in forming hypertrophic scars.

A hormone affects hair growth, certain molecules may prevent skin damage, a skin disease is linked to immune cells, glycerol helps skin hydration, and psoriasis treatment trials need improvement.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

A specific group of skin stem cells was found to help maintain hair follicle cells.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Brg1 is crucial for hair growth and skin repair by maintaining stem cells and promoting regeneration.

JAK inhibitors might help treat alopecia areata.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

A systems biology approach helps improve mesenchymal stromal cell therapies by mapping interactions and identifying treatment targets.

IL-17 and certain immune cells are linked to more severe alopecia areata.

TGFβ signaling prevents sebaceous gland cells from producing fats.

Modified stem cells that overexpress a specific protein can improve hair growth and reduce hair abnormalities in mice.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Low oxygen levels affect the behavior of certain proteins in human skin cells.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.